Skip to Content

MainStay Epoch US Equity Yield C EPLKX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 21.04  /  +0.53 %
  • Total Assets 1.0 Bil
  • Adj. Expense Ratio
    2.080%
  • Expense Ratio 2.080%
  • Distribution Fee Level High
  • Share Class Type Level Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 1.10%
  • Turnover 19%

USD | NAV as of Jul 12, 2024 | 1-Day Return as of Jul 12, 2024, 10:32 PM GMT+0

Morningstar’s Analysis EPLKX

Will EPLKX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Epoch US Equity Yield C's Average Process and People Pillar ratings are n't enough to prevent other weaknesses from sending this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings EPLKX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

2.49 25.0 Mil
Financial Services

Bank of America Corp

2.47 24.8 Mil
Financial Services

Eli Lilly and Co

2.40 24.1 Mil
Healthcare

MetLife Inc

2.18 21.8 Mil
Financial Services

Broadcom Inc

2.08 20.8 Mil
Technology

Merck & Co Inc

1.94 19.4 Mil
Healthcare

Cummins Inc

1.91 19.2 Mil
Industrials

AbbVie Inc

1.86 18.7 Mil
Healthcare

Walmart Inc

1.84 18.5 Mil
Consumer Defensive

MainStay US Government Liquidity I

1.84 18.4 Mil
Cash and Equivalents